1 |
Sheldon TA. Problems of using modelling in the economic evaluation of health care. Health Economics 1996;5(1):1-11.
DOI
ScienceOn
|
2 |
Guyatt G, Drummond M, Feeny D, Tugwell P, Stoddart G, Haynes RB, Bennett K, Labelle R. Guidelines for the clinical and economic evaluation of health care technologies. Social Science and Medicine 1986;22(4):393-408.
DOI
ScienceOn
|
3 |
Jefferson T, Demicheli V, Vale L. Quality of systematic reviews of economic evaluations in health care. Journal of Amerian Medical Association 2002;287:2809-2812.
DOI
ScienceOn
|
4 |
이태진. 약물경제성 평가 현황과 제도 도입방향. 주요 외국의 '약물경제성평가 및 성과연구' 현황과 시사점. 2003.
|
5 |
Davidoff AJ, Powe NR. The role of perspective in defining economic measures for the evaluation of medical technology. International Journal of Technology Assessment in Health Care 1996 Winter;12(1):9-21.
DOI
|
6 |
Luce BR, Elixhauser A. Estimating costs in the economic evaluation of medical technologies. International Journal of Technology Assessment in Health Care 1990;6(1):57-75.
DOI
|
7 |
김창엽, 이진석, 강길원, 김윤. 의료보험 환자가 병원진료시 부담하는 본인부담 크기. 한국보건행정학회지 1999;9(4):1-14.
과학기술학회마을
|
8 |
Drummond M and McGuire A (ed). Economic evaluation in health care, merging theory with practice. New York:Oxford University Press;2001.
|
9 |
Jacobs P, Roos NP. Standard cost lists for healthcare in Canada. Issues in validity and inter-provincial consolidation. Pharmacoeconomics 1999;15(6):551-60.
DOI
ScienceOn
|
10 |
Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Economics 1997 Sep-Oct;6(5):511-4.
DOI
ScienceOn
|
11 |
Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L. The friction cost method for measuring indirect costs of disease. Journal of Health Economics 1995;14(2):171-89.
DOI
ScienceOn
|
12 |
Commonwealth Department of Health and Ageing. Manual of resource items and their associated costs. Canberra. 2002. Available from http://www.health.gov.au/pbs/
pubs/manual
|
13 |
Ham C, Honigsbaum F. Priority setting and rationing health services.In : Saltman RB, Figueras J, Sakellarides S editors. Critical challenges for health care reform in
Europe. Philadelphia:Open University Press;1998.
|
14 |
Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. British Medical Journal 1996;313(3):275-83.
DOI
|
15 |
Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardisation of costs: the Dutch Manual for Costing in economic evaluations. Pharmacoeconomics 2002;20(7):443-54.
DOI
ScienceOn
|
16 |
Severens JL, van der Wilt GJ. Economic evaluation of diagnostic tests. A review of
published studies. International Journal of Technology Assessment in Health Care
1999;15(3):480-96.
DOI
|
17 |
Stolk EA, Brouwer WBF, Busschbach JJV. Rationalising rationing: economic and other considerations in the debate about funding of Viagra, Health Policy 2002;59(1):53-63.
DOI
ScienceOn
|
18 |
Hoffmann C, Graf von der Schulenburg JM. The influence of economic evaluation studies on decision making. A European survey. The EUROMET group. Health Policy 2000;52(3):179-92.
DOI
ScienceOn
|
19 |
Kanavos P, Trueman P, Bosilevac A. Can economic evaluation guidelines improve efficiency in resource allocation? The cases of Portugal, The Netherlands, Finland, and the United Kingdom. International Journal of Technology Assessment in Health Care 2000;16(4):1179-92.
DOI
ScienceOn
|
20 |
Elsinga E, Rutten FF. Economic evaluation in support of national health policy: the case of The Netherlands. Social Science and Medicine 1997;45(4):605-20.
DOI
ScienceOn
|
21 |
Oostenbrink JB, Buijs-Van der Woude T, van Agthoven M, Koopmanschap MA, Rutten FF. Unit costs of inpatient hospital days. Pharmacoeconomics 2003;21(4):263-71.
DOI
ScienceOn
|
22 |
Rutten F. Economic evaluation and health care decision-making. Health Policy
1996;36(3):215-29.
DOI
ScienceOn
|
23 |
Institute of Health Economics. A national list of provincial costs for health care. 1997;8.
|
24 |
Drummond M, O'Brien B, Stoddart G, et al. Methods of Economic Evaluation of Health Care Programmes. 2nd ed. New York:Oxford University Press;1997.
|
25 |
Graves N, Walker D, Raine R, Hutchings A, Roberts JA. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods. Health Economics 2002;11(8):735-739.
DOI
ScienceOn
|
26 |
Kernick D. Costing interventions in primary care. Family Practice 2000;17:6670.
|
27 |
Vissers JM. Health care management modelling: a process perspective. Health Care
Management Science 1998;1(2):77-85.
DOI
ScienceOn
|
28 |
Powe NR, Griffiths RI. The clinical-economic trial: promise, problems, and challenges. : Control Clinical Trials 1995;16(6):377-94.
DOI
ScienceOn
|
29 |
Halpern MT, McKenna M, Hutton J. Modeling in economic evaluation: an unavoidable fact of life. Health Economics 1998;7(8):741-742.
DOI
ScienceOn
|
30 |
Gold MR, Siegel ES, Russell LB, Weinstein MC. Cost effectiveness in health and medicine. New York:Oxford University Press;1996.
|
31 |
Stone PW, Chapman RH, Sandberg EA, Liljas B, Neumann PJ. Measuring costs in
cost-utility analyses. Variations in the literature. International Journal of Technology
Assessment in Health Care 2000;16(1):111-24.
DOI
ScienceOn
|
32 |
OECD. OECD review health care system Korea. 2003.
|
33 |
Zarnke KB, Levine MA, O'Brien BJ. Cost-benefit analyses in the health-care literature: don't judge a study by its label. Journal of Clinical Epidemiology 1997;50(7):813-22.
DOI
ScienceOn
|